Analysis of Impedimed Ltd (IPDQF)
Impedimed Ltd (IPDQF) has been showing some volatility in its stock price recently. The Relative Strength Index (RSI) values have been fluctuating around the mid-range, indicating a balanced market sentiment. The Moving Average Convergence Divergence (MACD) indicator has been crossing the signal line multiple times, suggesting potential shifts in momentum.
The stock price has been trading around $0.08, with some fluctuations in the past few days. The Moving Averages (SMA, EMA, WMA) have been relatively close to each other, indicating a stable trend. However, the recent price movements have shown some divergence from the moving averages, which could signal a potential change in trend.
Overall, Impedimed Ltd's stock seems to be in a consolidation phase, with mixed signals from technical indicators. Traders and investors may want to closely monitor the price movements and wait for clearer signals before making any trading decisions.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still projected to be positive.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, it's important to note that there is a wide range of forecasts, from a low of $164 to a high of $250. The current price of the security is $191.57, which is below both the average and median forecasted prices.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company. Here is a summary of the key data points:
1. Financials:
- Cash Flow: Operating cash flow (TTM) is $110,563,000,320 and levered free cash flow (TTM) is $84,726,874,112.
- Balance Sheet: Total cash (MRQ) is $67,150,000,128, total debt (MRQ) is $104,590,000,128, current ratio (MRQ) is 1.037, book value per share (MRQ) is $4.837, total cash per share (MRQ) is $4.379, and total debt to equity ratio (MRQ) is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue (TTM) is $381,623,009,280, diluted EPS (TTM) is $6.44, gross profit (TTM) is $169,148,000,000, revenue per share (TTM) is $24.537, net income to common (TTM) is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets (TTM): 22.073%
- Return on Equity (TTM): 147.25%
2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Average 10-Day Volume: 52,903,608
- Average 90-Day Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%
3. Valuation Metrics:
- PEG Ratio: 26.213
- Forward P/E: 26.213
- Trailing P/E: 29.429
- Enterprise Value: $2,948,462,018,560
- Price to Book (MRQ): 39.181
- Price to Sales (TTM): 7.615
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672
4. Stock Price Summary:
- Beta: 1.264
- 50-Day Moving Average: $173.6936
- 200-Day Moving Average: $180.7906
- 52-Week Low: $164.08
- 52-Week High: $199.62
- 52-Week Change: 8.253%
5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.53%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.51%
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a need for cost management or pricing adjustments.
3. The gross profit margin has remained relatively stable over the years, suggesting that the company has been able to maintain profitability despite the increase in sales and costs.
4. Operating income has also shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has been increasing consistently, reflecting the company's ability to manage its expenses and generate profits.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years, indicating growth in shareholder value.
7. The company has been able to generate significant EBITDA, which is a positive indicator of its operational performance.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant changes each year, with common stock repurchases and debt issuances impacting the cash flow.
6. Investing activities also vary, with acquisitions, investments, and capital expenditures affecting the cash flow.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in cash flow driven by financing and investing activities.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next year compared to the previous year. It indicates growth and improvement in the company's performance as projected by the analysts.MACD of IPDQF